High-tech CT scans: not a bad choice to test for clogge... (the University of Toronto in Canada; Mel...)

Related Image:

High-tech CT scans: not a bad choice to test for clogged arteries

(Date:7/24/2008)... A cleanroom manufacturing company has ...eanrooms. The feature is a utility panel which ca...nce the cleanroom appearance. , ...Gerbig Engineering, a designer, fabricator and ins...they are now offering a utility panel for integrat...

(Date:7/23/2008)...und,s Commitment to Meet the Financing Needs of Eu...and Institutions--, NEW YORK, July 24 /PRNewswire...n Macleod, Ph.D., has been promoted to Partner. Ba...s responsible for sourcing,evaluating and negotia...rtunities for the Paul Capital Healthcare funds., ...

(Date:7/23/2008)...M, N.C. A study out of Wake Forest University Bap...ctors are correctly identifying patients who are h...aven,t yet confirmed it. , The study used data f...ts with heart attack symptoms who were admitted to...g U.S. centers. , The findings were released to...

(Date:7/23/2008)...d Problem For 10+ Years Even Though Some Kilns Emi...n Cement Kilns in AL, CA, IA,IL, MD, MI, MT, NY, ...wire-USNewswire/ -- For more than a decade,after C...n from cement,kilns across the nation, the U.S. En...e action. Now, a new study from Earthjustice and t...

Breaking Medicine News(10 mins):Health News:Gerbig Engineering Announces Availability of Cleanroom Utility Panel 2 Health News:Paul Capital Partners Promotes Ken Macleod To Partner 2 Health News:Paul Capital Partners Promotes Ken Macleod To Partner 3 Health News:Study shows emergency physicians have good first instincts in diagnosing heart attacks 2 Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 2 Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 3 Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 4 Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 5 Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 6 Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 7

[0] Gerbig Engineering Announces Availability of Cleanroom Utility Panel [0] Paul Capital Partners Promotes Ken Macleod To Partner [0] Study shows emergency physicians have good first instincts in diagnosing heart attacks [0] Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA

...o run the U.S. Food and Drug Administration, said ...ure while scientific decisions were being made//. ...ffectiveness of medical endeavors, the appropriate...ration. Dr. Andrew Eschenbach, acting administrat...

...uth Wales has conducted a study which revealed tha...the user's physical health// . It is one of the ...Cannabis abuse can lead to cardiovascular, respira.... It can decrease short-term memory and also slow...

... from the University of Michigan and Harvard Unive...o explore how different regions// of the brain are...f brands and products. The study, forthcoming in t...e first to use fMRI to assess consumer perceptions...

...D is important for bone development and may help p... particularly// colorectal cancer.To be effective ... needed and this can be dangerous and toxis. Now, ...di Comprehensive Cancer Center indicates that it m...

Other Medicine News:Health News:FDA Nominee Says That He Is Not Influenced By Politics 2 Health News:Anticancer Properties of Vitamin D Revealed 2 Health News:Anticancer Properties of Vitamin D Revealed 3

FDA Nominee Says That He Is Not Influenced By Politics Tackling of Cannabis Addiction New Research Reveals How We Process Brands And Products Anticancer Properties of Vitamin D Revealed

(Date:7/23/2008)..., July 23 /- Sound Pharmaceuticals (S...ion with the FDA for the clinical,testing of a pro... of,chemotherapy induced hearing loss or ototoxici... will be tested in advanced stage lung cancer,and ...ased chemotherapy.,This marks the second developme...

(Date:7/23/2008)..., July 23 /- Dendreon Corpo...pects the Independent Data,Monitoring Committee (I...s,of overall survival relating to the Company,s Ph...inoma Treatment, also known as D9902B) clinical tr... Company,s investigational,active cellular immunot...

(Date:7/22/2008)...awards under Therapeutics Development Initiative b... to 23; next deadline January 20,2009, NEW YORK,... mission to,speed delivery of transformative treat...ael J. Fox Foundation for Parkinson,s Research has...stry research teams. The awards,were granted under...

(Date:7/22/2008)...frey Allan Will Stress the Importance to Patients ...Approval Pathway, RICHMOND, Va., July 22 /PRNewsw...developer of follow-on biologics and biopharmaceut... CEO of Insmed, will present at a,Congressional br...ignificant need for establishing an approval pathw...

Breaking Medicine Technology:Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer 2 Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2 Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3 Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4 Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2 Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3 Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2 Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3 Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp of Washington 1755 1 Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp of Washington 1755 2 Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp of Washington 1755 3 Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp of Washington 1755 4 Interferon does not slow or stop hepatitis C from worsening study finds 5962 1 Interferon does not slow or stop hepatitis C from worsening study finds 5962 2 UC San Diego Engineering Honor Society wins most outstanding chapter award 1161 1 UC San Diego Engineering Honor Society wins most outstanding chapter award 1161 2 Pill Poses Little Cervical Cancer Risk 5956 1 Pill Poses Little Cervical Cancer Risk 5956 2 Pill Poses Little Cervical Cancer Risk 5956 3

[0] Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer [0] Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October [0] Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics [0] Insmed CEO to Present at Congressional Briefing on Follow-On Biologics

...NEW YORK--(BUSINESS WIRE)--Apr 4, 2007 - ImClone S...rs Squibb Company (NYSE:,BMY) announced today that...imab) combined with platinum-based chemotherapy,me...val in patients,with recurrent and/or metastatic s...). The randomized, multi-center study, known as,EX...

...RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Apr...oday that following a,planned meeting of the indep...mpany,s ASSERT trial of senicapoc (formerly,ICA-17...dults, the,DMC recommended that the trial be termi...a reduction in crisis rate, the primary,endpoint. ...

Other Medicine Technology:Survival Data Available from Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer 2 Survival Data Available from Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer 3 Survival Data Available from Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer 4 Survival Data Available from Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer 5 Survival Data Available from Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer 6 Survival Data Available from Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer 7 Survival Data Available from Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer 8 Icagen Terminates Phase III ASSERT Study 2 Icagen Terminates Phase III ASSERT Study 3

Survival Data Available from Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer Icagen Terminates Phase III ASSERT Study

Our Tri-Flo® suction catheter design was created to be less traumatic to your patients while still providing high suctioning efficiency. Our infant and pediatric catheters (5/6, 8 or 10 Fr) featu

Tracheal Suction Latex Rubber Catheters - Funnel End

Rubber bronchial coude catheter, X-ray opaque, one eye, whistle tip.

KCIs KinAir IV combines Advanced Pressure Relief Therapy with a manual wound care turn to provide optimum skin care and patient,positioning.

Medicine Products:

AirLife™ Brand Tri-Flo® Single Catheters Tracheal Suction Latex Rubber Catheters - Funnel End Bronchial Suction Latex Rubber Catheters KinAir IV

High-tech CT scans: not a bad choice to test for clogge...(the University of Toronto in Canada; Mel...),Health